Connection
Michael Leibowitz to Carcinoma, Squamous Cell
This is a "connection" page, showing publications Michael Leibowitz has written about Carcinoma, Squamous Cell.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.833 |
|
|
|
-
Leibowitz MS, Srivastava RM, Andrade Filho PA, Egloff AM, Wang L, Seethala RR, Ferrone S, Ferris RL. SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells. Clin Cancer Res. 2013 Feb 15; 19(4):798-808.
Score: 0.292
-
Leibowitz MS, Ferris RL. Recurrence in head and neck squamous cell carcinoma. Editorial. Cancer. 2008 Aug 15; 113(4):671-3.
Score: 0.214
-
Leibowitz MS, Nayak JV, Ferris RL. Head and neck cancer immunotherapy: clinical evaluation. Curr Oncol Rep. 2008 Mar; 10(2):162-9.
Score: 0.208
-
Leibowitz MS, Andrade Filho PA, Ferrone S, Ferris RL. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes. Cancer Immunol Immunother. 2011 Apr; 60(4):525-35.
Score: 0.063
-
Davidson HC, Leibowitz MS, Lopez-Albaitero A, Ferris RL. Immunotherapy for head and neck cancer. Oral Oncol. 2009 Sep; 45(9):747-51.
Score: 0.056